2-((2S,3S)-2-HYDROXYPENTAN-3-YL)-4-(4-(PIPERAZIN-1-YL)PHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
UNII CQ4E5T9AWX
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-((2s,3s)-2-hydroxypentan-3-yl)-4-(4-(piperazin-1-yl)phenyl)-2,4-dihydro-3h-1,2,4-triazol-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CQ4E5T9AWX.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H25N5O2 ABWMMEGHWMLHAB-BBRMVZONSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-((2s,3s)-2-hydroxypentan-3-yl)-4-(4-(piperazin-1-yl)phenyl)-2,4-dihydro-3h-1,2,4-triazol-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.